Clinical
Warning after eye drop death
Health professionals have been advised to exercise extreme caution if considering off-label prescribing and supply of atropine eye drops, following the death of an adult patient The TGA has advised …
Shedding light on the evidence
Pharmacist interventions can achieve clinically relevant improvements for patients, but better quality of evidence is needed in the future, says Cochrane review lead author There is a need for better detailed …
Pharmacist services benefit inconclusive: Cochrane
A review of nearly 80 randomised trials has found pharmacist services for patients in the community had varying effects on outcomes compared with usual care A Cochrane systematic review has …
Community pharmacies effective at clinical services: review
A literature review has found CP interventions are accessible and effective, but argues research should look into how GP pharmacists may impact these Community pharmacies are well located to deliver …
Come fly with me
Is offering comprehensive travel health advice and assessment a future practice opportunity for pharmacists? Australian pharmacies could be looking to offer expanded travel health services as a future practice opportunity, …
Down the drain
Do pharmacies flush unwanted medicines down the toilet? Study reveals consumer confusion about what to do with expired and unwanted medicines A series of detailed consumer interviews has revealed the …
Prednisolone, methadone errors
Liquid doses prescribed in milligrams but dispensed as millilitres can lead to patients being given a dose five times higher than prescribed, says PDL Typically this time of year sees …
How the British do pharmacist prescribing
Pharmacist prescribing across community pharmacies and general practices in England has been lauded as a positive strategy in easing the load of overworked doctors Doctors across England are under “considerable …
Omega-3 evidence fishy… or not?
A recent Cochrane review found little evidence to support omega-3 supplements, but CMA urges consumers to look at the “large body of evidence” for their use Results of the recent …
Shortage continues
New notification of ‘tight supply’ of EpiPens, as stock shortages continue The TGA has renewed its advice about continuing issues with the supply of EpiPens in Australia. In the latest …
New guidelines for the management of heart failure and AF
Researchers have welcomed recommendations for use of SGLT2 inhibitors in patients with type 2 diabetes, CVD risk, and insufficient glycaemic control despite metformin The National Heart Foundation of Australia and …
‘So many women are living with this every day.’
The government has released Australia’s first National Action Plan for Endometriosis for women who it says have been “suffering in silence for far too long” “Early in 2008 while at …